SOD1 and Myelopathy: A paper from Turk et al. investigated the plasma activity of superoxide dismutase (SOD) in a cohort of ALD patients with different phenotypes; ten males with myelopathy, eight males with cerebral ALD, three female ALD patients, and nine age-matched healthy controls [61].